04/08/2026
FYI 👇👇👇
For those of you this affects we think you already know or have a plan in place. If not, worth taking a look at what Diabetes UK suggests below.
Last summer, the Government issued an alert to healthcare professionals about the discontinuation of Levemir insulin by pharmaceutical company Novo Nordisk, by the end of 2026.
While some people will have already switched to an alternative insulin, some may not have done so yet.
If you still take Levemir, and do not already have a diabetes appointment scheduled before the end of November 2026, please contact your diabetes team to arrange this appointment.
They'll be able to ensure your insulin switch is managed safely, while stocks of Levemir are still available.
There's no immediate action required beyond arranging your review.
➡️ Learn more: https://orlo.uk/sozJe